Followers | 88 |
Posts | 8196 |
Boards Moderated | 0 |
Alias Born | 06/17/2013 |
![](https://investorshub.advfn.com/uicon/404071.png?cb=1506674193)
Monday, October 26, 2015 10:18:23 AM
From Dr. Mahant’s CV at http://therapeuticsolutionsint.com/CV/Vijay-Mahant_CV.pdf
Partial list of Publications/Abstracts :
Over 17 articles published with the most relevant listed below:
· Flow-injection analysis with chemiluminescence detection in the determination of fluoroscein and fluorescamine-labeled species. Mahant V.K et al, Anal Chem. Acta, 145: 203-206 1983.
· The development of an ultra-sensitive two-site chemiluminometric assay for thyroid stimulating hormone. Vijay K. Mahant and Ashok Patel, Journal of Clinical Immunoassay, 11 (1), 1988 (abstract).
· A two-site chemiluminescence immunoassay for human prolactin. Vijay K. Mahant et al, Journal of Clinical Immunoassay, 11 (1), 1988 (abstract).
· Luminescent Labels, A review of properties and chemistry. F. McCapra, V.K. Mahant, et al, Journal of Bioluminescence and Chemiluminescence, 2 (4) 1988 (abstract).
· A sensitive enzyme-mediated chemiluminescence immunoassay for intact human parathyroid hormone. V.K. Mahant et al, Endocrine Society, 1990 (abstract).
· Development of enzyme-mediated chemiluminescence immunoassay for thyroid stimulating hormone. K. Nozawa-Ung, V.K. Mahant, et al, Journal of Clinical Immunoassay, 1990 (abstract).
· Development of enzyme-mediated chemiluminescence immunoassays for human luteinizing hormone and follicle stimulating hormone. G. Odstrchel et al, Bioluminescence and Chemiluminescence current status, edited by P. Stanley and L. Kricka, John Wiley & Sons, 1991 (p127).
· A sensitive enzyme-mediated chemiluminescence immunoassay for human chorionic gonadotropin. Vijay K. Mahant et al, Clinical Chemistry, 36 (6), 1990 (abstract).
· Development of a sensitive and specific immunoradiometric assay for human luteinizing hormone based on a modified avidin and biotin. Vijay K. Mahant et al, Journal of Clinical Immunoassay, 14 (1), 1991 (abstract).
· Development of immunoradimetric assays for luteinizing and follicle stimulating hormone using avidin-coated paramagnetic particles. V.K. Mahant et al, Journal of Clinical Immunoassay, (1992) (abstract).
· Development of an immunoradiometric assay for human prolactin using avidin-coated paramagnetic particles. V.K. Mahant et al, Clinical Chemistry, 38 (6), 1992 (abstract).
· Development of a sensitive immunoradiometric assay for thyroid stimulating hormone using avidin-coated paramagnetic particles. Vijay K Mahant et al, Journal of Clinical Immunoassay, 16 (1), 1993 (abstract).
· Development of a sensitive enzyme immunoassay for neonatal thyroid stimulating hormone. Vijay K Mahant et al, Clinical Chemistry, 39 (6), 1993 (abstract).
Recent TSOI News
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 05/31/2024 08:51:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/31/2024 04:47:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/31/2024 12:46:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/31/2024 12:44:01 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/30/2024 06:46:26 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2024 04:01:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 10:03:21 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 07:15:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 07:12:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 10:25:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 11:16:15 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/08/2024 05:15:25 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/06/2024 11:34:40 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 08:42:55 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/17/2024 11:15:01 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 01/04/2024 09:03:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 07:44:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 05:39:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/16/2023 11:17:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/16/2023 11:13:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 06:50:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 05:44:55 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 09:24:52 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2023 11:10:01 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM